Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection

被引:56
作者
Raboud, JM
Montaner, JSG
Conway, B
Haley, L
Sherlock, C
OShaughnessy, MV
Schechter, MT
机构
[1] UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER,BC V5Z 1M9,CANADA
[2] ST PAULS HOSP,CTR EXCELLENCE HIV AIDS,VANCOUVER,BC V6Z 1Y6,CANADA
[3] UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER,BC,CANADA
[4] ST PAULS HOSP,AIDS RES PROGRAMME,VANCOUVER,BC V6Z 1Y6,CANADA
[5] ST PAULS HOSP,DEPT PATHOL,VANCOUVER,BC V6Z 1Y6,CANADA
关键词
D O I
10.1093/infdis/174.1.191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Short-term variability in CD4 cell counts, plasma RNA levels, and p24 antigenemia was measured in clinically stable men with human immunodeficiency virus infection. Blood samples were obtained three times in each of 2 weeks 4 weeks apart. Differences between duplicate assays were considered to be due to technical factors; variation among visits was attributed to physiologic factors. Median enrollment values of CD4 cell counts, plasma RNA levels, and immune complex-dissociated (ICD) p24 antigenemia were 400 cells/mm(3), 3.4 log(10) copies/mL, and 38 pg/mL, respectively. Median absolute differences between duplicate CD4 cell counts, plasma RNA levels, and ICD p24 antigen were 16 cells/mm(3), 0.21 log(10) copies/mL, and 9.3 pg/mL. Median intraindividual ranges were 119 cells/mm(3), 0.83 log(10) copies/mL, and 18 pg/mL. Above 500 copies/mL, plasma RNA levels have a variability of 0.5 log(10); the test is unreliable below this level.
引用
收藏
页码:191 / 194
页数:4
相关论文
共 12 条
  • [1] PLASMA HIV-1 VIREMIA IN HIV-1 INFECTED INDIVIDUALS ASSESSED BY POLYMERASE CHAIN-REACTION
    AOKISEI, S
    YARCHOAN, R
    KAGEYAMA, S
    HOEKZEMA, DT
    PLUDA, JM
    WYVILL, KM
    BRODER, S
    MITSUYA, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (07) : 1263 - 1270
  • [2] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY
    COFFIN, JM
    [J]. SCIENCE, 1995, 267 (5197) : 483 - 489
  • [3] HOLODNIY M, 1994, J ACQ IMMUN DEF SYND, V7, P363
  • [4] DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS/MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL
    MONTANER, JSG
    SCHECHTER, MT
    RACHLIS, A
    GILL, J
    BEAULIEU, R
    TSOUKAS, C
    RABOUD, J
    CAMERON, B
    SALOMON, H
    DUNKLE, L
    SMALDONE, L
    WAINBERG, MA
    FANNING, M
    LALONDE, R
    BERGERON, M
    SCHLECH, W
    SALIT, I
    PHILLIPS, P
    SPIRA, B
    CONWAY, B
    CASSOL, S
    OSHAUGNESSY, M
    THORNE, A
    SINGER, J
    AUCLAIR, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) : 561 - 571
  • [5] STUDIES IN SUBJECTS WITH LONG-TERM NONPROGRESSIVE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    PANTALEO, G
    MENZO, S
    VACCAREZZA, M
    GRAZIOSI, C
    COHEN, OJ
    DEMAREST, JF
    MONTEFIORI, D
    ORENSTEIN, JM
    FOX, C
    SCHRAGER, LK
    MARGOLICK, JB
    BUCHBINDER, S
    GIORGI, JV
    FAUCI, AS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 209 - 216
  • [6] RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67
  • [7] DIRECT MEASUREMENT OF VIREMIA IN PATIENTS INFECTED WITH HIV-1 AND ITS RELATIONSHIP TO DISEASE PROGRESSION AND ZIDOVUDINE THERAPY
    SEMPLE, M
    LOVEDAY, C
    WELLER, I
    TEDDER, R
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1991, 35 (01) : 38 - 45
  • [8] STREINER DL, 1989, HLTH MEASUREMENTS CA
  • [9] BIOLOGICAL VARIATION AND QUALITY-CONTROL OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA QUANTITATION BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION
    WINTERS, MA
    TAN, LB
    KATZENSTEIN, DA
    MERIGAN, TC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (11) : 2960 - 2966
  • [10] QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS PROVIRUS AND CIRCULATING VIRUS - RELATIONSHIP WITH IMMUNOLOGICAL PARAMETERS
    YERLY, S
    CHAMOT, E
    HIRSCHEL, B
    PERRIN, LH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) : 269 - 276